Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial.
Gheorghiade M, Gattis WA, O'Connor CM, Adams KF Jr, Elkayam U, Barbagelata A, Ghali JK, Benza RL, McGrew FA, Klapholz M, Ouyang J, Orlandi C; Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure (ACTIV in CHF) Investigators. Gheorghiade M, et al. Among authors: gattis wa. JAMA. 2004 Apr 28;291(16):1963-71. doi: 10.1001/jama.291.16.1963. JAMA. 2004. PMID: 15113814 Clinical Trial.
Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure.
Gheorghiade M, Gattis WA, Barbagelata A, Adams KF Jr, Elkayam U, Orlandi C, O'Connor CM; Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure Investigators. Gheorghiade M, et al. Among authors: gattis wa. Am Heart J. 2003 Feb;145(2 Suppl):S51-4. doi: 10.1067/mhj.2003.154. Am Heart J. 2003. PMID: 12594452 Clinical Trial. No abstract available.
Vasopressin: a new target for the treatment of heart failure.
Lee CR, Watkins ML, Patterson JH, Gattis W, O'connor CM, Gheorghiade M, Adams KF Jr. Lee CR, et al. Am Heart J. 2003 Jul;146(1):9-18. doi: 10.1016/S0002-8703(02)94708-3. Am Heart J. 2003. PMID: 12851603 Review.
Rationale and design of the pilot randomized study of nesiritide versus dobutamine in heart failure (PRESERVD-HF).
Gheorghiade M, Gattis WA, Adams KF Jr, Jaffe AS, O'Connor CM; Pilot Randomized Study of Nesiritide versus Dobutamine in Heart Failure; Duke University Cooperative Cardiovascular Studies Investigators. Gheorghiade M, et al. Among authors: gattis wa. Am Heart J. 2003 Feb;145(2 Suppl):S55-7. doi: 10.1067/mhj.2003.155. Am Heart J. 2003. PMID: 12594453 Clinical Trial. No abstract available.
58 results